The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Open accessAbstract
Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. Diagnosis of CAPA remains challenging, mainly because bronchoalveolar lavage fluid galactomannan testing and culture, which represent the most sensitive diagnostic tests for aspergillosis in the ICU, are hindered by the fact that bronchoscopies are rarely performed in COVID-19 patients due to the risk of disease transmission. Similarly, autopsies are rarely performed, which may result in an underestimation of the prevalence of CAPA. Finally, the treatment of CAPA is complicated by drug–drug interactions associated with broad spectrum azoles, renal tropism and damage caused by SARS-CoV-2, which may challenge the use of liposomal amphotericin B, as well as the emergence of azole-resistance. This clinical reality creates an urgency for new antifungal drugs currently in advanced clinical development with more promising pharmacokinetic and pharmacodynamic profiles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Donnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1008 · Cited by 2,917
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045 · cited 1×
“This suggests that while sustained innate immune function leads to hyperinflammation [37], lymphocyte numbers decline, and their function may be defective.”
BackgroundClinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,008
Multiorgan and Renal Tropism of SARS-CoV-2
Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · cited 1×
“This concern is particularly relevant for patients infected by SARS-CoV-2 which has shown renal tropism and been described as a frequent cause of kidney injury [87].”
BackgroundRawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa530 · Cited by 1,662
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationChronic infections and coronary heart disease: is there a link?
Danesh, J., Collins, R., & Peto, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03079-1 · Cited by 1,211
Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02232-10 · Cited by 1,108
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
Lescure, F.-X., Bouadma, L., Nguyen, D., Parisey, M., Wicky, P.-H., Behillil, S., Gaymard, A., Bouscambert-Duchamp, M., Donati, F., Le Hingrat, Q., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30200-0 · Cited by 1,092
Chen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa449 · Cited by 1,020
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., Wang, X., Hu, C., Ping, R., Hu, P., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0543oc · Cited by 942
Lin, L., Lu, L., Cao, W., & Li, T. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1746199 · Cited by 914
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Schauwvlieghe, A. F. A. D., Rijnders, B. J. A., Philips, N., Verwijs, R., Vanderbeke, L., Van Tienen, C., Lagrou, K., Verweij, P. E., Van de Veerdonk, F. L., Gommers, D., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30274-1 · Cited by 886
Self-citationViral and host factors related to the clinical outcome of COVID-19
Zhang, X., Tan, Y., Ling, Y., Lu, G., Liu, F., Yi, Z., Jia, X., Wu, M., Shi, B., Xu, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2355-0 · Cited by 885
The clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Toniati, P., Piva, S., Cattalini, M., Garrafa, E., Regola, F., Castelli, F., Franceschini, F., Airò, P., Bazzani, C., Beindorf, E.-A., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102568 · Cited by 751
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 694
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
Blot, S. I., Taccone, F. S., Van den Abeele, A.-M., Bulpa, P., Meersseman, W., Brusselaers, N., Dimopoulos, G., Paiva, J. A., Misset, B., Rello, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-1978oc · Cited by 628
Co-infection with respiratory pathogens among COVID-2019 cases
Zhu, X., Ge, Y., Wu, T., Zhao, K., Chen, Y., Wu, B., Zhu, F., Zhu, B., & Cui, L. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198005 · Cited by 607
COVID-19 Associated Pulmonary Aspergillosis
Koehler, P., Cornely, O. A., Böttiger, B. W., Dusse, F., Eichenauer, D. A., Fuchs, F., Hallek, M., Jung, N., Klein, F., Persigehl, T., et al. (2020) · Mycoses · doi:10.1111/myc.13096 · Cited by 547
Self-citationInfluenza virus-related critical illness: pathophysiology and epidemiology
Kalil, A. C., & Thomas, P. G. (2019) · Critical Care · doi:10.1186/s13054-019-2539-x · Cited by 524
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
Mazzoni, A., Salvati, L., Maggi, L., Capone, M., Vanni, A., Spinicci, M., Mencarini, J., Caporale, R., Peruzzi, B., Antonelli, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138554 · Cited by 502
The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
Liu, T., Zhang, J., Yang, Y., Ma, H., Li, Z., Zhang, J., Cheng, J., Zhang, X., Zhao, Y., Xia, Z., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012421 · Cited by 498
Aspergillus fumigatus morphology and dynamic host interactions
van de Veerdonk, F. L., Gresnigt, M. S., Romani, L., Netea, M. G., & Latgé, J.-P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.90 · Cited by 490
Pulmonary fibrosis secondary to COVID-19: a call to arms?
Spagnolo, P., Balestro, E., Aliberti, S., Cocconcelli, E., Biondini, D., Casa, G. D., Sverzellati, N., & Maher, T. M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30222-8 · Cited by 481
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
Netea, M. G., Giamarellos-Bourboulis, E. J., Domínguez-Andrés, J., Curtis, N., van Crevel, R., van de Veerdonk, F. L., & Bonten, M. (2020) · Cell · doi:10.1016/j.cell.2020.04.042 · Cited by 468
Self-citationPrevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
Alanio, A., Dellière, S., Fodil, S., Bretagne, S., & Mégarbane, B. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30237-x · Cited by 457
Totura, A. L., Whitmore, A., Agnihothram, S., Schäfer, A., Katze, M. G., Heise, M. T., & Baric, R. S. (2015) · mBio · doi:10.1128/mbio.00638-15 · Cited by 455
Marshall, R. P., Webb, S., Bellingan, G. J., Montgomery, H. E., Chaudhari, B., McAnulty, R. J., Humphries, S. E., Hill, M. R., & Laurent, G. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108086 · Cited by 412
Shi, C.-S., Nabar, N. R., Huang, N.-N., & Kehrl, J. H. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0181-7 · Cited by 404
COVID-19 pandemic—a focused review for clinicians
Cevik, M., Bamford, C. G. G., & Ho, A. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.04.023 · Cited by 392
Critchley, J. A., Carey, I. M., Harris, T., DeWilde, S., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc18-0287 · Cited by 391
Co-infections: potentially lethal and unexplored in COVID-19
Cox, M. J., Loman, N., Bogaert, D., & O'Grady, J. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30009-4 · Cited by 381
COVID-19–associated Pulmonary Aspergillosis
van Arkel, A. L. E., Rijpstra, T. A., Belderbos, H. N. A., van Wijngaarden, P., Verweij, P. E., & Bentvelsen, R. G. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1038le · Cited by 370
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
McCreary, E. K., & Pogue, J. M. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa105 · Cited by 334
de Luca, A., Smeekens, S. P., Casagrande, A., Iannitti, R., Conway, K. L., Gresnigt, M. S., Begun, J., Plantinga, T. S., Joosten, L. A. B., van der Meer, J. W. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322831111 · Cited by 313
A Dynamic Immune Response Shapes COVID-19 Progression
Ong, E. Z., Chan, Y. F. Z., Leong, W. Y., Lee, N. M. Y., Kalimuddin, S., Haja Mohideen, S. M., Chan, K. S., Tan, A. T., Bertoletti, A., Ooi, E. E., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.021 · Cited by 289
Wauters, J., Baar, I., Meersseman, P., Meersseman, W., Dams, K., De Paep, R., Lagrou, K., Wilmer, A., Jorens, P., & Hermans, G. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2673-2 · Cited by 265
COVID-19-associated invasive pulmonary aspergillosis
Rutsaert, L., Steinfort, N., Van Hunsel, T., Bomans, P., Naesens, R., Mertes, H., Dits, H., & Van Regenmortel, N. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00686-4 · Cited by 247
Dimopoulos, G., de Mast, Q., Markou, N., Theodorakopoulou, M., Komnos, A., Mouktaroudi, M., Netea, M. G., Spyridopoulos, T., Verheggen, R. J., Hoogerwerf, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.007 · Cited by 245
Self-citationIannitti, R. G., Napolioni, V., Oikonomou, V., De Luca, A., Galosi, C., Pariano, M., Massi-Benedetti, C., Borghi, M., Puccetti, M., Lucidi, V., et al. (2016) · Nature Communications · doi:10.1038/ncomms10791 · Cited by 235
Self-citationInfluenza-associated Aspergillosis in Critically Ill Patients
van de Veerdonk, F. L., Kolwijck, E., Lestrade, P. P. A., Hodiamont, C. J., Rijnders, B. J. A., van Paassen, J., Haas, P.-J., Oliveira dos Santos, C., Kampinga, G. A., Bergmans, D. C. J. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2540le · Cited by 230
Wahidi, M. M., Lamb, C., Murgu, S., Musani, A., Shojaee, S., Sachdeva, A., Maldonado, F., Mahmood, K., Kinsey, M., Sethi, S., et al. (2020) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000000681 · Cited by 230
Cleavage of Fibrinogen by Proteinases Elicits Allergic Responses Through Toll-Like Receptor 4
Millien, V. O., Lu, W., Shaw, J., Yuan, X., Mak, G., Roberts, L., Song, L.-Z., Knight, J. M., Creighton, C. J., Luong, A., et al. (2013) · Science · doi:10.1126/science.1240342 · Cited by 220
Cornely, O. A., Hoenigl, M., Lass‐Flörl, C., Chen, S. C. ‐., Kontoyiannis, D. P., Morrissey, C. O., Thompson, G. R., & for the Mycoses Study Group Education and Research Consortium (MSG‐ERC) and the European Confederation of Medical Mycology (ECMM) (2019) · Mycoses · doi:10.1111/myc.12960 · Cited by 215
Self-citationMyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Sheahan, T., Morrison, T. E., Funkhouser, W., Uematsu, S., Akira, S., Baric, R. S., & Heise, M. T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000240 · Cited by 207
Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management
Lestrade, P. P. A., Meis, J. F., Melchers, W. J. G., & Verweij, P. E. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.027 · Cited by 202
Diagnosing COVID-19-associated pulmonary aspergillosis
Verweij, P. E., Gangneux, J.-P., Bassetti, M., Brüggemann, R. J. M., Cornely, O. A., Koehler, P., Lass-Flörl, C., van de Veerdonk, F. L., Chakrabarti, A., & Hoenigl, M. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30027-6 · Cited by 181
Self-citationBorger, P., Koëter, G. H., Timmerman, J. A. B., Vellenga, E., Tomee, J. F. C., & Kauffman, H. F. (1999) · The Journal of Infectious Diseases · doi:10.1086/315027 · Cited by 165
Danger‐associated molecular patterns ( DAMPs ) in acute lung injury
Tolle, L. B., & Standiford, T. J. (2013) · The Journal of Pathology · doi:10.1002/path.4124 · Cited by 157 · cited 1×
“The first involves the release of danger-associated molecular patterns (DAMPs), signal molecules released by dying or damaged cells that act as endogenous danger signals to promote and exacerbate the immune and inflammatory response leading to lung injury [16].”
BackgroundAder, F., Nseir, S., Berre, R. L., Leroy, S., Tillie‐Leblond, I., Marquette, C., & Durocher, A. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01143.x · Cited by 145
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient
Blaize, M., Mayaux, J., Nabet, C., Lampros, A., Marcelin, A.-G., Thellier, M., Piarroux, R., Demoule, A., & Fekkar, A. (2020) · Emerging infectious diseases · doi:10.3201/eid2607.201603 · Cited by 142
Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside
Aruanno, M., Glampedakis, E., & Lamoth, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00399-19 · Cited by 136
Diagnosis and treatment of invasive fungal infections: looking ahead
Sanguinetti, M., Posteraro, B., Beigelman‐Aubry, C., Lamoth, F., Dunet, V., Slavin, M. A., & Richardson, M. D. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz041 · Cited by 129
Chindamporn, A., Chakrabarti, A., Li, R., Sun, P., Tan, B. H., Chua, M. M., Wahyuningsih, R., Patel, A. K., Liu, Z., Chen, Y., et al. (2017) · Medical Mycology · doi:10.1093/mmy/myx066 · Cited by 124
Jenks, J. D., Salzer, H. J. F., Prattes, J., Krause, R., Buchheidt, D., & Hoenigl, M. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s145545 · Cited by 119
Self-citationInvasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report
Prattes, J., Valentin, T., Hoenigl, M., Talakić, E., Reisinger, A. C., & Eller, P. (2020) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2020.05.001 · Cited by 112
Self-citationMeijer, E. F. J., Dofferhoff, A. S. M., Hoiting, O., Buil, J. B., & Meis, J. F. G. M. (2020) · Journal of Fungi · doi:10.3390/jof6020079 · Cited by 111
Wang, J., Yang, Q. H., Zhang, P., Sheng, J., Zhou, J., & Qu, T. (2020) · Critical Care · doi:10.1186/s13054-020-03046-7 · Cited by 111
Cenci, E., Mencacci, A., Casagrande, A., Mosci, P., Bistoni, F., & Romani, L. R. (2001) · The Journal of Infectious Diseases · doi:10.1086/322793 · Cited by 110
Eigl, S., Hoenigl, M., Spieß, B., Heldt, S., Prattes, J., Neumeister, P., Wölfler, A., Rabensteiner, J., Prüller, F., Krause, R., et al. (2016) · Medical Mycology · doi:10.1093/mmy/myw102 · Cited by 102
Self-citationThe Danger Signal S100B Integrates Pathogen– and Danger–Sensing Pathways to Restrain Inflammation
Sorci, G., Giovannini, G., Riuzzi, F., Bonifazi, P., Zelante, T., Zagarella, S., Bistoni, F., Donato, R., & Romani, L. R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001315 · Cited by 100
Wiederhold, N. P., Locke, J. B., Daruwala, P., & Bartizal, K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky280 · Cited by 91
Hoenigl, M., Duettmann, W., Raggam, R. B., Seeber, K., Troppan, K. T., Fruhwald, S. M., Prüller, F., Wagner, J., Valentin, T., Zollner‐Schwetz, I., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00251-13 · Cited by 89
Self-citationIdentification of Mycoses in Developing Countries
Arastehfar, A. A., Wickes, B. L., İlkit, M., Pincus, D., Daneshnia, F., Pan, W., Fang, W., & Boekhout, T. (2019) · Journal of Fungi · doi:10.3390/jof5040090 · Cited by 89
Self-citationBassetti, M., Giacobbe, D. R., Grecchi, C., Rebuffi, C., Zuccaro, V., Scudeller, L., Akova, M., Alastruey‐Izquierdo, A., Arıkan-Akdağlı, S., Azoulay, É., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.065 · Cited by 86
Self-citationInvasive Aspergillosis as an Under-recognized Superinfection in COVID-19
Thompson, G. R., Cornely, O. A., Pappas, P. G., Patterson, T. F., Hoenigl, M., Jenks, J. D., Clancy, C. J., & Nguyen, M. H. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa242 · Cited by 86
Self-citationJenks, J. D., Mehta, S. R., Taplitz, R., Aslam, S., Reed, S. L., & Hoenigl, M. (2018) · Mycoses · doi:10.1111/myc.12881 · Cited by 82
Self-citationBroad spectrum triazoles for invasive mould infections in adults: Which drug and when?
Jenks, J. D., Mehta, S. R., & Hoenigl, M. (2018) · Medical Mycology · doi:10.1093/mmy/myy052 · Cited by 82
Self-citationDAMP signaling in fungal infections and diseases
Cunha, C., Carvalho, A., Esposito, A., Bistoni, F., & Romani, L. R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00286 · Cited by 69
Self-citationClark, C., & Drummond, R. A. (2019) · Pathogens · doi:10.3390/pathogens8020045 · Cited by 66
Bassetti, M., Scudeller, L., Giacobbe, D. R., Lamoth, F., Righi, E., Zuccaro, V., Grecchi, C., Rebuffi, C., Akova, M., Alastruey‐Izquierdo, A., et al. (2018) · Mycoses · doi:10.1111/myc.12869 · Cited by 65
Self-citationBaniasadi, S., Farzanegan, B., & Alehashem, M. S. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0086-4 · Cited by 64
Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge
Antinori, S., Rech, R., Galimberti, L., Castelli, A., Angeli, E., Fossali, T., Bernasconi, D. P., Covizzi, A., Bonazzetti, C., Torre, A., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101752 · Cited by 61
Influenza-Associated Pulmonary Aspergillosis: A Local or Global Lethal Combination?
Rijnders, B. J. A., Schauwvlieghe, A. F. A. D., & Wauters, J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa010 · Cited by 60
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3523861 · Cited by 55
Cunha, C., Giovannini, G., Pierini, A., Bell, A. S., Sorci, G., Riuzzi, F., Donato, R., Rodrigues, F. J. S., Velardi, A., Aversa, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027962 · Cited by 53
Self-citationAirway mycosis in allergic airway disease
Li, E., Knight, J. M., Wu, Y., Luong, A., Rodríguez, A., Kheradmand, F., & Corry, D. B. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.05.002 · Cited by 51
COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report
Sharma, A. K., Hofmeyr, A., Bansal, A., Thakkar, D., Lam, L., Harrington, Z., & Bhonagiri, D. (2020) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2020.06.002 · Cited by 41
Nield, B., Larsen, S. R., & van Hal, S. J. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz303 · Cited by 37
Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
Lahmer, T., Rasch, S., Spinner, C. D., Geisler, F., Schmid, R. M., & Huber, W. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.05.032 · Cited by 37
Stanzani, M., Vianelli, N., Cavo, M., Kontoyiannis, D. P., & Lewis, R. E. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.04.002 · Cited by 35
Hoenigl, M., Prattes, J., Neumeister, P., Wölfler, A., & Krause, R. (2017) · Mycoses · doi:10.1111/myc.12727 · Cited by 34
Self-citationImproving the rates ofAspergillusdetection: an update on current diagnostic strategies
Jenks, J. D., Salzer, H. J. F., & Hoenigl, M. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1558054 · Cited by 34
Self-citationHigh Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill COVID-19 Patients
Alanio, A., Dellière, S., Fodil, S., Bretagne, S., & Mégarbane, B. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3575581 · Cited by 27
Hotez, P. J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012313 · Cited by 16
Cited by
Koehler, P., Bassetti, M., Chakrabarti, A., Chen, S. C. A., Colombo, A. L., Hoenigl, M., Klimko, N., Lass-Flörl, C., Oladele, R. O., Vinh, D. C., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30847-1 · Cited by 951
Self-citationGarg, D., Muthu, V., Sehgal, I. S., Ramachandran, R., Kaur, H., Bhalla, A., Puri, G. D., Chakrabarti, A., & Agarwal, R. (2021) · Mycopathologia · doi:10.1007/s11046-021-00528-2 · Cited by 579
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Self-citationHoenigl, M., Salmanton-García, J., Walsh, T. J., Nucci, M., Neoh, C. F., Jenks, J. D., Lackner, M., Sprute, R., Al-Hatmi, A. M. S., Bassetti, M., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30784-2 · Cited by 470
Self-citationThe Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs · doi:10.1007/s40265-021-01611-0 · Cited by 467
Self-citation
Metadata
- Authors
- Arastehfar, A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P., Krause, R., Cornely, O. A., S. Perlin, D., Lass-Flörl, C., & Hoenigl, M.
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2020-06-24
- Volume
- 6
- Issue
- 2
- Pages
- 91
- ISSN
- 2309-608X (ISSN-L)
- OpenAlex
- W3036214010
- Cited by
- 421
- References
- 98
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.